肾上腺素加入局麻药用于椎管内及区域麻醉的获益与风险:随机对照试验的Meta分析及试验序贯分析
该系统评价纳入70项随机试验(3644例患者),比较局麻药联合肾上腺素与单用局麻药在椎管内或区域麻醉中的获益与风险。试验序贯分析表明,椎管内麻醉中加入肾上腺素可延长镇痛和运动阻滞不超过60分钟,但对硬膜外麻醉或腰硬联合麻醉的影响尚不确定。
要点
- 椎管内麻醉加肾上腺素延长镇痛和运动阻滞不超过60分钟。
- 硬膜外麻醉加肾上腺素未显示降低术后疼痛强度或术中低血压风险。
- 区域神经阻滞加肾上腺素可延长镇痛时间约66分钟。
核心结论
- 椎管内或区域麻醉局麻药中加入肾上腺素延长镇痛和运动阻滞不超过60分钟。
- 硬膜外麻醉或腰硬联合麻醉中加入肾上腺素的影响仍不确定。
研究设计与样本
- 系统评价与Meta分析,纳入70项随机对照试验,共3644例患者,来自17个国家,1970年至2017年。
- 使用Cochrane偏倚风险工具评估质量,随机效应模型,并进行试验序贯分析。
主要发现
- 椎管内麻醉加肾上腺素延长运动阻滞(WMD 64分钟;99% CI 37-91)、镇痛(WMD 34分钟;99% CI 6-62)和两节段消退时间(WMD 20分钟;99% CI 11-28)。
- 区域神经阻滞加肾上腺素延长镇痛时间(WMD 66分钟;98% CI 32-100)。
- 硬膜外麻醉加肾上腺素未显示降低术后疼痛强度30%或影响术中动脉低血压风险。
关键数值与推荐
- 试验序贯分析设定检测30%-50%的效果增减,α水平调整为1%。
- 椎管内麻醉加肾上腺素延长运动阻滞WMD 64分钟(99% CI 37-91)。
- 椎管内麻醉加肾上腺素延长镇痛WMD 34分钟(99% CI 6-62)。
- 区域神经阻滞加肾上腺素延长镇痛WMD 66分钟(98% CI 32-100)。
临床怎么用
- 椎管内或区域麻醉中可考虑加肾上腺素以延长镇痛和运动阻滞,但延长不超过60分钟。
- 硬膜外麻醉或腰硬联合麻醉中加入肾上腺素的效果不确定,需个体化决策。
局限性
- 试验序贯分析信息量不足以得出肾上腺素对硬膜外麻醉中运动阻滞、低血压、尿潴留或静息疼痛强度影响的结论。
- 腰硬联合麻醉中信息量不足以得出对运动阻滞或低血压影响的结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This systematic review examines the benefit and harm of adding epinephrine to local anesthetics for epidural, intrathecal, or locoregional anesthesia. METHODS: We searched electronic databases to October 2017 for randomized trials comparing any local anesthetic regimen combined with epinephrine, with the same local anesthetic regimen without epinephrine, reporting on duration of analgesia, time to 2 segments regression, or any adverse effects. Trial quality was assessed using the Cochrane risk of bias tool and a random-effects model was used. Trial sequential analyses (TSA) were applied to identify the information size (IS; number of patients needed to reach a definite conclusion) and were set to detect an increase or decrease of effect of 30%-50%, depending on the end point considered. Alpha levels were adjusted (1%) for multiple outcome testing. RESULTS: We identified 70 trials (3644 patients, 17 countries, from 1970 to 2017). Median number of patients per trial was 44 (range, 9-174). Thirty-seven trials (1781 patients) tested epinephrine for epidural, 27 (1660) for intrathecal, and 6 (203) for locoregional anesthesia (sciatic, femoral, popliteal, axillary blocks). TSA enabled us to conclude that adding epinephrine to epidural local anesthetics could not decrease postoperative pain intensity by 30%, and did not impact the risk of intraoperative arterial hypotension. IS was insufficient to conclude on the impact of epinephrine on the risk of motor block (IS, 4%), arterial hypotension (20%), urinary retention (23%), or pain intensity at rest (27%) during labor. TSA confirmed that adding epinephrine to intrathecal local anesthetics increased the duration of motor block (weighted mean difference [WMD] 64 minutes; 99% CI, 37-91), analgesia (WMD 34 minutes; 99% CI, 6-62), and the time to 2 segments regression (WMD 20 minutes; 99% CI, 11-28). IS was insufficient to conclude on its impact on arterial hypotension (IS, 15%), or when administrated in a combined spinal-epidural, on motor block (IS, 11%) or arterial hypotension (IS, 11%). Adding epinephrine to local anesthetics for a locoregional block increased the duration of analgesia (WMD 66 minutes; 98% CI, 32-100]). CONCLUSIONS: Adding epinephrine to intrathecal or locoregional local anesthetics prolongs analgesia and motor block by no more than 60 minutes. The impact of adding epinephrine to epidural local anesthetics or to a combined spinal-epidural remains uncertain.
引用
- Tschopp C, Tramèr MR, Schneider A, et al. Benefit and Harm of Adding Epinephrine to a Local Anesthetic for Neuraxial and Locoregional Anesthesia: A Meta-analysis of Randomized Controlled Trials With Trial Sequential Analyses. Anesth Analg. 2018. PMID: 29782398. doi:10.1213/ANE.0000000000003417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。